What Commission Decision of 26/06/2007 declaring a concentration to be compatible with the common market (Case No COMP/M.4704 - BRIDGEPOINT / GAMBRO HEALTHCARE) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic) requires
On 26 June 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market…
This is a preview. The full record adds the complete summary, 9 workflow steps, 11 schema fields and 8 primary citations. Start a free trial or see pricing.
Pillar: Legal & IP Sovereignty · Authority: European Commission · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32007M4704
SHA-256 integrity: a0d6134dd52d2b335b845820364a8335c285c4553f500d9297a82cfb1a33edad
Primary Citations — 8 traced to source
- Decision Date: 'On 26 June 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market.'
- Legal Basis: 'This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004.'
+ 6 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-celex-32007m4704.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-celex-32007m4704.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-celex-32007m4704
- Back to registry: Browse all 10,084 compliance nodes